Effect of crucumin on vascular endothelial function in atherosclerotic rabbits

Zhongguo Zhongyao Zazhi

Volumn 38, Issue 19, 2013, Pages 3343-3347

  Chen, Xiao ^a   Lin, Yi Nuo ^a   Fang, Dan Hong ^a   Zhang, Huai Qin ^a   Huang, Wei Jian ^a  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Asymmetric dimethylarginine; Atherosclerosis; Crucumin; Nitric oxide; Nitric oxide synthase

Indexed keywords

CHOLESTEROL; CONSTITUTIVE NITRIC OXIDE SYNTHASE; CURCUMIN; ENDOTHELIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; EXPERIMENTAL RABBIT; HEART PROTECTION; HISTOPATHOLOGY; LIPID DIET; LOW DRUG DOSE; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR ENDOTHELIUM;

ANIMALS; ARGININE; ATHEROSCLEROSIS; CURCUMIN; ENDOTHELIUM, VASCULAR; MALE; NITRIC OXIDE SYNTHASE; RABBITS;

EID: 84890331667     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20131925     Document Type: Article

References (7)

1. Toggweiler S, Schoenenberger A. The prevalence of endothelial dysfunction in patients with and without coronary artery disease [J]. Clin Cardiol, 2010, 33(12): 746.
2. Rungseesantivanon S, Thenchaisri N. Curcumin supplementation could improve diabetes-induced endothelial dysfunction associated with decreased vascular superoxide production and PKC inhibition [J]. BMC Complement Altern Med, 2010, 10: 57.
3. Sagiroglu T, Kanter M. Protective effect of curcumin on cyclosporin A-induced endothelial dysfunction, antioxidant capacity, and oxidative damage [J]. Toxicol Ind Health, 2013, Jul 18.
4. Coban D, Milenkovic D, Chanet A, et al. Dietary curcumin inhibits atherosclerosis by affecting the expression of genes involved in leukocyte adhesion and transendothelial migration [J]. Mol Nutr Food Res, 2012, 56(8): 1270.
5. Cooke J P. Does ADMA cause endothelial dysfunction [J]. Arte-rioscler Thromb Vasc Biol, 2000, 20: 2032.
6. Siroen M P, Teerlink T, Nijveldt R J, et al. The clinical significance of asymmet ric dimethylarginine [J]. Annu Rev Nutr, 2006, 26: 203.
7. Schulze F, Lenzen H, Hanefeld C, et al. Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter coronary artery risk determination investigating the influence of ADMA concentration (CARDIAC) study [J]. Am Heart J, 2006, 152: 493.e1.